January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

The mystery of early embryonic communication is starting to be unraveled thanks to a new stem cell-based model.

NIH opens federal funding for 13 embryonic stem cell lines, will review 96 more. Dec. 2, 2009— -- The National Institutes of Health announced it will make 13 new embryonic stem cell lines will be ...

Senescence. It’s a beautiful-sounding word whose tones suggest it should be a perfume or an essential oil. But that’s not ...

Although embryonic stem cells (ESCs) have been successfully derived from mice and rats, efforts to establish chimeric and germline-competent ESC lines in species beyond rodents have been unsuccessful.

Between 1998 and 2009, research being conducted using human embryonic stem (hES) cells expanded primarily using private funds because of restrictions on the use of federal funds for such research.

A stretch of viral DNA in the mouse genome gives cells in early-stage embryos the potential to become almost any cell type in ...

Glycolysis is an ancient metabolic activity. It consists of a set of reactions that convert glucose into energy. This central process allows cells to grow, divide, and stay alive. It has accompanied ...

Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.

At Yale, researchers are using stem cells to grow brain organoids for psychiatric research, regenerate tissues for cancer patients and reprogram blood to reverse immune aging. Despite political ...